Learning Objectives

Upon completion of this webinar recording, participants will better understand:

• Review the definition of Laboratory Developed Tests, LDTs
• Understand CLIA and FDA regulations surrounding LDTs
• Review current Legislative Proposals that could impact the regulations surrounding LDTs: the VITAL Act and the VALID Act
• Discuss the HHS announcement
• Understand staffing and CLIA complexity requirements to perform LDTs
• Review recent COVID lab market updates

Panelists

• Kimberly Zunker, Consulting Manager at Accumen
• Jon Harol, President at Lighthouse Labs